Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Metlen signs gallium supply agreement with unnamed US tech firm

(Sharecast News) - Greek aluminium producer Metlen Energy & Metals on Wednesday said it had signed a long‑term supply gallium agreement with an unnamed US technology company.

Metlen did not disclose the value of the contract but said it will take around 25% of the company's annual output and described it as the first major commercial gallium deal between a European producer and a US tech firm.

The company plans to begin gallium production in 2027, increasing to 50 tonnes a year by 2028, a level it said would be sufficient to meet the European Union's entire demand for the critical mineral.

Gallium - increasingly in demand - is used in defence applications, AI hardware and high‑performance semiconductors, and has become a strategic focus for Western governments after China - which has historically dominated global production - placed restrictions on exports.

Metlen said its gallium investment has been designated a strategic project under the EU's Critical Raw Materials Act, which aims to boost domestic supply of key materials needed for the bloc's energy transition and security.

The European Commission last year identified 47 strategic projects, including in Greece, to support the development of critical raw‑materials production.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Wizz Air H1 profits slide on rising fuel costs, Middle East disruption
(Sharecast News) - Wizz Air posted a drop in first-half profit on Thursday as the budget airline was hit by rising fuel costs and disruption in the Middle East.
Syncona NAV rises as Beacon breakthrough boosts valuation
(Sharecast News) - Life sciences investor Syncona reported a 3% increase in net asset value per share in the first half, driven by positive clinical trial results from portfolio company Beacon Therapeutics, as it reiterated plans to return at least £250m to shareholders.
3i Group shares jump as Action growth drives returns, buyback unveiled
(Sharecast News) - Shares in 3i Group jumped on Thursday morning after the private equity investor reported further growth at its largest portfolio company, Action, and announced a fresh £750m share buyback programme.
Burberry backs FY growth outlook as profit more than triples, luxury demand strengthens
(Sharecast News) - Luxury fashion house Burberry reported a sharp improvement in first-half profitability on Thursday and reiterated its confidence in delivering revenue growth and margin expansion this year, as it extended its run of positive comparable sales growth to a fifth consecutive quarter.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.